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Summary 
The human cell line T2 has been reported to be class I assembly deficient, and accordingly expresses 
reduced amounts of HLA-A2 and no HLA-B5 at the cell surface. By immunoblotting we observe 
the steady-state  class I heavy chain levels of T2 to be near normal when compared with the 
identical class I alleles of the wild-type cell line T1. In pulse chase experiments, formation of 
heavy chain/3z-microglobulin complexes is observed for both HLA-A2 and HLA-B5. Culture 
at reduced temperatures (26 or 20~  does not increase the amount of class I molecules transported, 
unlike what has been reported for the class I assembly-deficient mouse mutant cell line RMA-S. 
The HLA-B5 and the HLA-A2 complexes formed by T2 are thermolabile in cell lysates, albeit 
to different degrees. The thermolability of HLA-B5 can be overcome by addition of HLA-B5- 
presentable peptides, obtained by trifluoroacetic acid extraction from an HLA-B5-positive cell 
line, underlining the necessity of peptide for class I stability and indicating that T2-derived class 
I complexes are devoid of peptide. Cytoplast fusion of T2 cells with RMA-S cells shows the 
defect in class I assembly of RMA-S to be similar to that of T2. Localization of class I molecules 
observed by immuno-electron microscopy reveals the accumulation in the T2 cell line of both 
HLA-B5 and HLA-A2 in the endoplasmic reticulum (ER). Class I molecules are present in all 
the cisternae  of the Golgi complex of T2, but the ratio of HLA-A and -B locus products in 
the Golgi area differs significantly from that at the cell surface. We conclude that the requirement 
for peptide in transport of class I molecules manifests itself at a stage beyond the ER,  most 
likely the Golgi area. 
H 
LA class I molecules consist of an MHC-encoded heavy 
chain, the light chain 13z-microglobulin (132M),  1 and 
a third subunit, a peptide of 8-10 amino acids (1-3).  It is 
this ternary complex that is seen by the TCR. Mutant cell 
lines with deficiencies in class I expression have been particu- 
larly useful in elucidating the assembly and intracellular trans- 
port pathways of MHC products. 
The T2 cell line (4, 5) was produced by fusion of the B 
lymphoblastoid cell line .174, carrying a deletion in the MHC 
class II area, with the T cell line CEM. The fusion product 
(T1) was selected for loss of CEM-derived chromosome 6, 
resulting in the cell line T2. The T2 and .174 cell lines have 
very similar phenotypes, and have been described as being 
unable to properly assemble MHC class I molecules, based 
largely on the reduced cell surface expression of HLA-A2, 
1 Abbreviations used in this paper:/~2M, •2-microglobulin; endo H, endo- 
glycosidase H, ER, endoplasmic reticulum. 
and on the absence of HLA-B5 molecules at the cell surface. 
As peptides are now recognized to be the essential third subunit 
of class I molecules, the inability of T2 cells to engage in 
HLA-A2-restricted antigen presentation is in accordance with 
the suggestion that peptide loading of class I molecules is 
deficient in this cell line (6, 7). Biochemical analysis in sup- 
port of the claim of impaired assembly has relied on the use 
of antibodies that react equally well with free class I heavy 
chains and properly assembled  class I molecules (8-10). 
Other mutants have been described that resemble T2 in 
their defect in class I assembly, notably the murine cell line 
RMA-S (11). It has been claimed for both T2 and RMA-S 
that addition of presentable peptides induces assembly of the 
class I molecules from the constituent subunits (12, 13). Het- 
erodimeric class I molecules formed by RMA-S appear to be 
"empty" (14); they lack peptide and display  a number of 
remarkable properties. They are far more potent in their ability 
to bind peptide than class I molecules obtained from normal 
cells. They also are thermolabile. When exposed to tempera- 
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with properly occupied class I molecules are lost, without 
destruction of the class I heavy chain itself, a phenomenon 
interpreted as partial unfolding of the ala2 domain of the 
heavy chain. After exposure to elevated temperature, the ability 
to bind peptide is irreversibly  lost. Peptide not only fulfills 
the role of the nominal antigen recognized by the T  cell, 
but is also required for the proper structure or possibly even 
assembly of class I molecules. 
Assembly of heavy chain, light chain, and peptide takes 
place relatively early in the biosynthetic pathway. Empty dass 
I molecules are formed in the course of biosynthesis and are 
also present at the cell surface (15). Whether the normal route 
of assembly proceeds predominantly via a peptide-class I heavy 
chain intermediate, or via a class I-~2M "empty" hetero- 
dimer (16), remains to be established.  Cells that are unable 
to deposit class I molecules at the cell surface have been claimed 
to accumulate class I molecules in the endoplasmic reticulum 
(Elk), but no direct cytochemical data in support of this state- 
ment are available (13, 17). In other cell lines with a deficiency 
in class I expression, the class I molecules have been reported 
to recycle between the ER and the cis-Golgi complex (18). 
We have investigated the early steps in biosynthesis of class 
I molecules in the T2 cell line, and conclude that initial as- 
sembly of the heavy chain and/32M apparently does take 
place normally, but yields conformationally  labile complexes 
that can be successfully stabilized by the addition of peptide. 
Here we have used class I locus-specific antibodies to deter- 
mine the intracellular localization of the class I products in 
the T1 and T2 cell lines. The transport defect in T2 manifests 
itself at the level of the Golgi compartment, as well as by 
retention of class I molecules in the ER. 
The defect causing impaired HLA class I assembly and trans- 
port in T2 has been mapped to a large deletion in the HLA 
class II region of the MHC. It is now known that several 
genes involved in HLA class I assembly are localized in this 
region, in particular,  the genes encoding proteins with struc- 
tural similarity to ATP-binding peptide transporters (TAP1 
and TAP2, previously PSF1/2, HAM1/2 in humans and mice, 
respectively),  but also genes encoding cytosolic proteasome 
components (19-23,  reviewed  in reference  24).  Both types 
of proteins are likely to be involved in the provision of pep- 
tides to the Elk-resident class I heavy chain and/32M. We 
show that interspecific complementation of the defect in the 
T2 cell line can be achieved by fusion of T2 with lkMA, but 
that the defect in T2 fails to be complemented by fusion with 
RMA-S, indicating functionally  similar proteins to be affected 
in the latter two cell lines. 
Materials and Methods 
Cell Culture.  Cell lines were cultured in DMEM (Gibco BRL, 
Gaithersburg, MD) containing 10% FCS, supplemented with 2 
mM t-glutamine,  and antibiotics. For cells cultured at 260C or 
20~  25 mM Hepes buffer (Flow Laboratories,  Inc., McLean,  VA), 
pH 7.4, was added to the medium. 
Immunoprecipitation and Antibodies.  The protocol used for im- 
munoprecipitation  and neuraminidase  treatment of immunoprecipi- 
rates has been described in detail (25). In short, labeled cells are 
lysed in NP-40 containing lysis  buffer (0.5% NP-40 [BDH Chem- 
icals, Poole, England], 50 mM Tris, pH 7.4, 5 mM MgC12). Ly- 
sates are precleared  by incubation with 2/~l normal mouse serum 
for 45 rain, followed by addition of formalin-fixed Staphylococcus 
aureus in quantities sufficient for complete removal of antibody 
during the 30-rain incubation. This is repeated  once, to ensure  com- 
plete removal  of aspecific  binding protein. Subsequently,  precipita- 
tion with specific antibodies are performed. Precipitated material 
is washed four times before resuspension of  the pellet in IEF sample 
buffer for analysis  by IEF gel electrophoresis. All immunoprecipi- 
tations and washing of precipitated material are done on ice. Anti- 
bodies used are W6/32 (26), rabbit anti-free heavy chain serum 
(27), HC-10 and HC-A2 (28), anti-P53 (29), anti-galactosyl trans- 
ferase (30). Neuraminidase (type VIII) was obtained from Sigma 
Chemical Co. (St. Louis, MO). 
IEE  One-dimensional IEF gel electrophoresis was performed 
as described (25). Gels were fluorographed  using DMSO/diphenyl- 
oxazole (PPO), and labeled proteins were detected by autoradiog- 
raphy to Kodak XAR-5 films. 
Pulse-Chase Analysis.  24  x  1@ cells were labeled for 5 min 
with 250/zCi [3SS]methionine, (sp act 1,200 Ci/mmol; Amersham 
Corp., Arlington Heights, IL), and after addition of 1 mM cold 
L-methionine, 3  x  106 cells per time point were harvested and 
lysed in NP-40 lysis mix. To the NP-40 lysis mix, 0.1 mM PMSF 
and 1/zg/ml trypsin inhibitor was added freshly  in all experiments. 
Class I Stability Assay.  16  x  l& cells were labeled with 250 
/zCi 3SS-methionine for 30 rain in the presence of 5/xg/ml BFA 
(a kind gift of the Sandoz Co., Basel, Switzerland), preventing the 
acquisition of sialic acid residues by the heavy chain, facilitating 
the observation of differences  in the amount of heavy chain recov- 
ered in these experiments. This procedure has no effect  on stability 
as assayed  here, as labeling in the absence of BFA gives equivalent 
results. After lysis in 800/zl NP-40 lysis mix, to which 10 mg/ml 
OVA (Sigma  Chemical  Co.) was added, 100 #1 lysate,  corresponding 
to 2  x  106 cells, was incubated for 1 h at the temperatures indi- 
cated. Immunoprecipitations from the lysate  were performed as de- 
scribed. 
TFA Extract Pre~ration and Class I Stabilization.  TFA-extractable 
material was isolated from 10  s cells by incubation with 4 ml 0.1% 
TFA, 0.9% NaC1 for 30 min, at room temperature. Extracts were 
lyophilized and resuspended in water three times to remove TFA, 
and stored at  -20~  taken up in a final volume of 3 ml water. 
11  x  106 T2 cells were labeled for I h with 250 #Ci [3SS]methio- 
nine. After lysis in 1 ml NP-40 lysis mix,  to lysate of 105 cells, 
TFA-extracted material in the amounts indicated and NP-40 lysis 
mix (total volume of 250/~1) was added. After a 30-min incubation 
on ice, mixtures were incubated for 1 h at 37~  and immunopre- 
cipitation and IEF analysis were performed as described. 
Western Blot Analysis.  5 x  105 cells per lane resuspended in 40 
/xl IEF sample buffer were loaded and run on IEE After IEF and 
Western blotting (31), the rabbit anti-heavy chain serum (dilution 
1:3,000) was used as first antibody, and peroxidase-conjugated  goat 
anti-rabbit  Ig antibody (dilution 1:1&; Sigma Chemical Co.) as 
second antibody. Chemiluminescence (RPN 2106 kit; Amersham 
Corp.,  Arlington  Heights,  IL) and exposure to film (Xomat-S, 
Kodak) was used to detect antibody reactivity. 
Cytoplast Fusions.  This protocol was adapted from reference 
32.  9  x  106 T2 cells were labeled for 30 min with 250  ~tCi 
3SS-methionine, and washed once with DMEM. 9 x  105 unlabeled 
fusion partner cells were mixed with 1.5  x  l& labeled T2 cells, 
mixed, and taken up in 3 ml DMEM, to which PHA (HA-16; Well- 
come Diagnostics, Beckenham, UK) was added to a final concen- 
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(Falcon 3001; Becton  Dickinson  & Co., Mountain View, CA) coated 
with poly-r-lysine. Coating was done by incubation with 4 ml 10 
#g/ml poly-r-lysine  HBr, molecular  weight 70,000-150,000 (Sigma 
Chemical Co.) in PBS for 1 h at room temperature, followed by 
repeated washing with water. Coated dishes were stored dry, at 
4~  Cells were incubated for 1 h at 37~  and washed two times 
with DMEM without FCS. To the cells to be fused, 250 #1 50% 
(wt/vol)  polyethylene glycol 1000 (BDH Chemicals, Poole, En- 
gland) in PBS was added, and cells were fused for 1 rain at 37~ 
After fusion, cells were washed three times with DMEM free of 
FCS, and after addition of  3 ml DMEM containing 10% FCS, they 
were cultured for 3 h at 37~  Cells were lysed in 1 ml NP-40 
lysis mix,  and precipitations were performed as described. 
Immunoelectron Microscopy.  Aliquots of T1 and T2 cell were 
mixed before fixation with 0.1 M phosphate buffer, 2% glutaralde- 
hyde for 2 h at room temperature. Ultrathin cryosections and im- 
munogold labeling were performed as described (33). Briefly,  after 
fixation, cells  were washed twice with 0.1 M phosphate buffer and 
twice with PBS, 0.15 M glycine. After embedding in 10% gelatin, 
at 4~  small pieces of gelatin were infiltrated with 2.3 M sucrose, 
mounted, and frozen  in liquid nitrogen. Ultrathin cryosections  were 
immuno-double labeled  with mAbs HC-10, HC-A2, P53, or rabbit 
anti-galactosyl transferase  polyclonal serum. To visualize the anti- 
bodies, 15- and 10-nm gold particles  bound to protein A were used. 
For visualization  of mAbs HC-A2 and P53, rabbit anti-mouse IgG1 
was used as a bridging antibody between the primary mAb and 
the protein A-gold complex. Neglectible  low background gold was 
found without use of the first antibody. To determine the distribu- 
tion of HC-10 and HC-A2 for T1 and T2,  the number of gold 
particles representing  HC-A2  and  HC-10 were  quantitated  in 
double-labeled  sections.  Only gold particles  within 20 nm of  a mem- 
brane were counted. For each cell type, 26 cells were randomly 
selected and the gold particles for HC-10 and HC-A2 were counted 
directly in  the microscope at  an instrumental  magnification of 
10,000. To determine the ratio of HC-10 over HC-A2 in the Golgi 
complex, 35 Golgi areas were counted for both T1 and T2. The 
background labeling as determined for nucleus and mitochondria 
was 3%. Before mixing of T1 and T2 cells, we showed these to 
be cell populations homogeneous in class I labeling. T1 and T2 
cells could therefore be distinguished unequivocally after mixing 
and processing of the samples. 
Results 
High Steady-State Levels of  Class I Heavy Chains in T2.  The 
total levels of class I heavy chains in T1  and T2  at steady 
state were assessed after separation of the subunits by IEF 
under denaturing conditions. Immunoblots were prepared 
using a rabbit-anti-class I heavy chain serum (27) and chemi- 
luminescence for detection (Fig. 1). Densitometry of autora- 
diograms shows that the T2 cell line still contains relatively 
high levels of HLA-A2 and HLA-B5 heavy chains, estimated 
at ",~50-70%o of the total heavy chain level observed for T1. 
It is concluded that the HLA class I heavy chains present 
in T2 are rather stable  and remain present for a prolonged 
time. For T1, the interpretation of  the IEF pattern is compli- 
cated by the presence of sialylated HLA-B5 and the presence 
of the HLA-Aw30 and -Bw6 specificities, all showing con- 
siderable overlap in the focusing positions of their heavy chains. 
About 30% of the HLA-A2 heavy chains present in T2 carry 
Figure 1.  Steady-state  HLA levels in T1 and 
T2. Total  cell  lysate  of  equal amounts  ofT1 and 
T2 cells  was run on IEF, and, after  immunoblot- 
ting, heavy  chains  were  detected  using  the rabbit 
anti-heavy  chain  reagent. Focusing  positions of 
unsialated and of the different  sialylated  forms 
of the HLA class I products are indicated.  Note 
the complete  absence  of sialylated  forms  of HLA- 
B5 in T2. 
sialic acids, whereas no sialated B5 heavy chains can be de- 
tected at steady-state levels in T2. The extent of sialylation 
observed for the HLA-A2 heavy chain at steady state is in 
good agreement with the levels of surface-expressed HLA-A2 
detected by cytofluorimetry  (4), and by immuno-electron mi- 
croscopy (see below). Separation by IEF not only allows reso- 
lution of different allelic products, but also of their modi- 
fications,  in particular the addition of sialic acids. Addition 
of sialic acids is reported to take place in the trans-Golgi com- 
plex and trans-Golgi network. 
Proper  Assembly of Class I Complex, but with Reduced  Affinity 
for {3zM in  the  T2  Cell Line.  Pulse-chase  labeling experi- 
ments were performed on T1 and T2, and immunoprecipi- 
tates were prepared with the W6/32 antibody (Fig. 2). The 
reactivity of W6/32  has been carefully determined and is 
known to depend on proper association of class I heavy chain 
with ~zM (26). 
The extent of intracellular transport of class I molecules 
may be  judged from the acquisition of sialic acids by the heavy 
chains, resulting in a more acidic isoelectric point. In the T1 
cell  line, both HLA-A2 and HLA-B5 undergo this modi- 
fication, which for both appears to be complete after 45 rain 
of chase. 
For the T2 cell line, expressing only HLA-A2 and HLA- 
BS,  W6/32 clearly recovers a complex of heavy chain and 
~2M,  for both HLA-A2 and -BS.  Note,  however,  the de- 
crease in the quantity of/~2M recovered for T2, when com- 
pared with T1. Densitometry reveals that in the W6/32 im- 
munoprecipitates from T2, approximately fourfold less B2M 
is present than in those prepared from T1.  This difference 
cannot be accounted for solely by the different amounts of 
class I products at steady state, which differ by no more than 
a factor of 2 (Fig.  1). Because W6/32 fails to react with free 
heavy chains, loss of ~2M from the immunoprecipitated class 
I molecules must have taken place in the course of the experi- 
ment, suggesting an intrinsic decrease in the stability of class 
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(a) and T2 (b). Cells  were  pulse  labeled  for 5 rain and chased  for the times 
indicated, at either 26~  or 37~  Immunoprecipitates  were analyzed  by 
IEF and detected  by autoradiography.  Focusing  positions of the different 
sialylated forms of HLA-A2 and -B5 and of B2M are indicated. 
I  molecules of T2.  Assembly is  not impaired in a  major 
way, because the relative amounts of HLA-A2 and -B5 heavy 
chains recovered by W6/32 for T2 show only very little re- 
duction, when compared with T1.  Whereas some sialyla- 
tion  is  observed  for  HLA-A2,  we  have  consistently been 
unable to observe  this modification for the HLA-B5 com- 
plex (Figs. 1 and 2). 
The  Transport Defect of T2 Cannot Be Rescued by Reduced 
Temperature.  Can the defect in transport of HLA class I mol- 
ecules in the cell line T2 be rescued by reduced temperature, 
as  was  reported  for  the  H-2K  b and D b molecules in  the 
mouse mutant cell line RMA-S? Pulse-chase experiments were 
therefore performed at reduced temperatures. When T2 cells 
were  chased  at  26~  the  rate,  but  not  the  extent  of 
modification, was reduced for HLA-A2 (Fig.  2 b).  We did 
not observe  any sialylation of the HLA-B5 heavy chain at 
26~  (Fig.  2  b),  or at 20~  (not  shown). 
The class I molecules in T2 remain largely endoglycosi- 
dase H  (endo H) sensitive (8, Baas et al.; data not shown). 
Densitometry revealed  that at  most 30%  of the W6/32- 
reactive  class I  molecules acquired endo H  resistance  after 
prolonged chase (data not shown), again consistent with the 
Figure 3.  Stability  of HLA molecules  of T1 and T2 in cell lysates at 
different  temperatures. (a) Material  precipitated  by W6/32 from T1 (top) 
and T2 (bottom)  after  incubation  of the lysate  for 1 h at the temperatures 
indicated.  Analysis  by IEF and detection  by autoradiography  was performed 
for all immunoprecipitates.  IEF positions  of the relevant  subunits  are indi- 
cated. (b) Free heavy  chains precipitated subsequently  from the same cell 
lysates. 
level of HLA-A2 surface expression observed by cytofluorim- 
etry (see also Fig.  1). 
Thermotability of HLA-B5 and HLA-A2 in T2.  The class 
I molecules produced by T2 have been reported to behave 
similarly,  from a functional point of view,  to those synthe- 
sized by the murine cell line RMA-S (12). In detergent ly- 
sates, empty murine class I molecules undergo an irreversible 
conformational change at 37~  prevented by prior interac- 
tion with presentable peptides.  The issue of stability of class 
I molecules was therefore explored further by exposing de- 
tergent lysates of labded human T1 and T2 cells to increasing 
temperatures. For T1, lysates could be exposed  to tempera- 
tures as high as 40~  without significant loss of W6/32- 
reactive material (Fig. 3 a). For the T2 cell line, the HLA-A2 
molecules were rather resistant, and showed only slightly re- 
duced recovery from lysates exposed to temperatures >35~ 
However, the HLA-B5 molecules in T2 are dearly less stable 
than those in T1, also when compared with HLA-A2 in the 
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tide. Cell lysate of 106 metabolically labeled T2 cells was incubated with 
the indicated amounts of TFA-extracted material for 30 min before ex- 
posure for 1 h to 37~  or 4~  The W6/32 immunoprecipitates  were 
analyzed by IEF and detected by autoradiography. The focusing position 
of the HLA-B5 chain is indicated. 
T2 cell line. The absence of class I complexes from T2 cell 
lysates exposed to elevated temperatures is not accompanied 
by increased breakdown of heavy chains. Free heavy chains, 
known to be rather susceptible to proteolysis, were recov- 
ered in near constant amounts from the lysate regardless of 
temperature of exposure (Fig. 3 b).  The net loss observed 
for dass I molecules therefore entirely applies to W6/32- 
reactive material 
Stabilization of  HLA-B5 by TFA-extracted  Naturally Processed 
Peptides.  Since no HLA-B5-presentable peptides have been 
identified to date, we extracted the naturally processed pep- 
tides from properly folded HLA-B5 molecules with TFA (34), 
to assess the stabilizing capacity of  HLA-B5-presentable pep- 
tides. Lysates from the T2 cell line were exposed at 37~ 
in the absence or presence of increasing amounts of TFA- 
extracted material from the HLA-B5 homozygous cell line 
Basilio, to TFA extracts from the T2 cell line itself, and from 
RMA-S (Fig. 4). Only TFA extracts from Basilio were capable 
of  conferring thermostability, and did so in a dose-dependent 
fashion. We thus suggest that the HLA-B5 molecules pro- 
duced by T2 are indeed largely empty, as deduced by their 
ability to be protected from thermal unfolding by the inclu- 
sion of proper peptides, present in TFA extracts. Moreover, 
these HLA-B5 molecules fail to be transported to the com- 
partment where sialyl transferases act, presumed to be the 
trans-Golgi complex or the trans-Golgi reticulum. 
Subcelhlar Localization of Class I  Molecules Analyzed  by 
Immuno-electron Microscot,/.  The intracellular distribution of 
class I molecules was analyzed by immuno-electron micros- 
copy. We have developed two mAbs,  HC-10,  and HC-A2, 
both of which were raised against purified flee heavy chains 
of HLA-B and -A locus products,  respectively (28). In im- 
munoblots, these reagents show strong preference  for the prod- 
ucts of the locus against which the antibody was raised. Both 
HC-10 and HC-A2 react well on ultrathin cryosections, and 
in this sense are unique reagents. The widely different levels 
of plasma membrane labeling of class I molecules for T1 and 
T2 cells observed allowed their simultaneous fixation and fur- 
ther processing as a mixture of cells, while permitting un- 
ambiguous identification of each cell type. Thus, conditions 
for fixation, sectioning, and labeling were identical for both 
cell types. For the T1 cell line, HC-A2 and HC-10 reactivity 
was observed throughout the biosynthetic pathway, and on 
the cell surface. The reduction in labeling of the plasma mem- 
brane of T2 with HC-A2 is in good agreement with cyto- 
fluorimetry data,  and also with the results from the pulse 
chase analysis (Fig. 5 a). The ratio of total plasma membrane 
labeling  for T2  relative  to  T1  is  7%  (HC-10)  and  23% 
(HC-A2).  For T2,  the cell surface labeling  observed with 
HC-10 is likely to be due to crossreactivity with HLA-A2 
(28). If B5 were indeed completely absent from the cell sur- 
face of T2, this level of crossreactivity cannot exceed 20%. 
Quantitation of ER-localized labeling (Fig. 5, B and C; 
Table 1) shows a sixfold relative increase in both HC-10 and 
HC-A2 labeling for T2 when compared with T1. Accumu- 
lation thus dearly takes place in the ER ofT2 for both alleles. 
In the Golgi area, labeling in all Golgi cisternae is observed 
in the T2 cell line for both HC-10 and HC-A2 (Fig. 6, A 
and B). Using P53 as a marker for the c/s-Golgi  complex (29), 
and galactosyl transferase as a marker for trans-Gol~ local- 
ization (30), (Fig. 6,  C  and D), we note that HC-10 and 
HC-A2 reactivity is present throughout the Golgi complex 
of T2, including the trans-Gol~ area. The ratio of HC-10- 
to HC-A2-reactive material in the Golgi complex is similar 
to T1 and T2 (1.3), whereas this ratio differs strongly for 
the plasma membrane. We thus conclude that the transport 
defect in T2 manifests itself not only in the ER, but also 
in the Golgi area. 
The Class I Assembly-deficient  Mouse Cell Line RMA-S Fails 
to Rescue the T2 Pkenotype in Cytoplast  Fusions.  For T2, the 
exact mutation that leads to the failure to assemble class I 
molecules  is  known to  include  at  least  the deletion of a 
presumptive  peptide  transporter (19, 35),  and in addition, 
an MHC-encoded subunit of a proteasome is lacking. To es- 
tablish whether the defect in T2 can be complemented by 
RMA-S, cytoplast fusions of T2 cells with RMA-S cells were 
performed (Fig. 7). 
T2  cells were labeled  with  [3SS]methionine, and fused 
with a large excess  of  unlabeled  cells, for which T1, T2, RMA, 
and RMA-S were used. Only when T2 was fused with RMA 
or T1 did we observe sialylation of HLA-B5,  indicative of 
transport of HLA-B5. Interspecific complementation of the 
transport defect in the T2 cell line can thus be achieved. The 
decreased  recovery  by W6/32 of  HLA-B5 upon fusion or mock 
fusion with the routine cell lines (Fig. 7 a) can likely be at- 
tributed to the loss of human ~2M from the HLA-B5 mol- 
ecules in the course of the experiment due to their intrinsic 
instability, and subsequent association thereof with murine 
class I heavy chains. Increased recovery of labeled B2M after 
fusion or mock fusion with T1 or with T2 (Fig. 7 b) may 
be attributed to binding of labeled, T2-derived 32M to cold 
heavy chains present in excess  in the lysate. The defect in T2 
cannot be complemented by RMA-S. 
151  Baas et al. Figure 5.  Immunogold  detection 
of  HC-A2 (10 nm gold)  and HC-10 
(15 nm gold). Bar: 0.1/xm. (A) Pe- 
ripheral parts ofT1 (bottom) and T2 
(top) ceils, showing  the low cell  sur- 
face expression  of class I on T2 as 
compared  with  T1. (B) T1 cells  with 
abundant labeling at  the  plasma 
membrane, but only  little HC-A2 
and HC-10 labeling  in the ER (be- 
tween  arrowheads) and nuclear  enve- 
lope (NE). (C) T2 cells showing 
heavier  labeling  of the Elk (between 
arrowheads)  and nuclear envelope 
when compared with T1 (B). 
The reverse experiment, fusion of pulse-labeled  RMA-S 
with unlabded human cells, gave equivocal results,  presum- 
ably because  a transient reduction in temperature, difficult 
to avoid in the course of the fusion experiment, results in 
appreciable  modification and transport of the mouse class I 
molecules (see reference  17;  data not shown). 
Discussion 
The T2 cell line has been reported to be deficient in as- 
sembly and intracellular transport of HLA class I molecules. 
Not all class I alleles are affected equally: a low level of HLA- 
A2, but no HLA-BS, is detected at the cell surface  (4,  5). 
The early stages of biosynthesis of HLA class I molecules 
were studied in the T2 cell line by pulse-chase analysis. The 
epitope recognized by the W6/32 antibody is known to be 
critically dependent on the presence  of fl2M,  and W6/32- 
reactive class I molecules therefore contain flzM. Properly as- 
sembled W6/32-reactive complexes of both HLA-A2 and 
HLA-B5 are formed in the T2 cell line at a rate and extent 
similar, if not identical, to those observed for T1. These com- 
plexes remain present for a prolonged time, as is the case for 
152  Stabilization  and Localization  of Empty HLA Class I Complexes Figure 6.  (A and B) Immuno- 
gold detection of HC-A2 (10 nm 
gold) and HC-10 (15 nm gold) in 
the Golgi areas of T1 (A) and T2 
(B). Bar: 0.2/zm. (C and D) Golgi 
distribution in T2 of  HC-10 (15 nm 
gold) and c/s-Golgi  marker P53 (10 
nm gold; (C)  and antigalactosyl 
transferase  (10 nm gold;  D) is shown. 
HC-10 labeling can be seen in all 
stacks of the Golgi area. Bar: 0.2 
/~m. (C) cis-Golgi; (T) trans-Golgi. 
Table  1.  Distribution  of the Immuno-gold Labeling for HC-IO 
and HC-A2 of TI  and T2 
T1  T2 
HC-10  HC-A2  HC-10  HC-A2 
Plasma membrane  83  91  16  70 
Etk  10  3  69  20 
Golgi  4  2  6  2 
Endosomes/lysosomes  3  4  9  8 
Numbers are percentage  of total label observed  for the indicated mem- 
brane fractions. 
the HLA complexes formed by the wild-type cell line T1. 
Transport of the HLA-B5 complex to the trans-Golgi com- 
plex, or trans-Gol# reticulum, is not detectable in T2, as  judged 
by the failure of the HLA-B5 heavy chain to acquire sialic 
acids. The level of sialylation of HLA-A2 seen in pulse-chase 
experiments indeed matches  the level of surface expressed 
HLA-A2 as observed by cytofluorimetry, as well as by anal- 
),sis of steady-state levels of HLA-A2, A decrease in the tem- 
perature of culture does not improve transport to the cell 
surface of either HLA-A2 or HLA-BS, unlike the case for 
class I products of the murine mutant cell line RMA-S (11). 
If the defect of T2 resembles that of RMA-S,  as has been 
suggested (13),  the lack of transport of HLA class I mole- 
cules at reduced temperature reflects either a property unique 
to human class I molecules, or it may be an indication that 
153  Baas et  al. Figure  7.  Cytoplast fusion experiments. After fusion, W6/32-reactive 
material was analyzed by IEF and autoradiography.  Half of the immuno- 
precipitated material was first treated with neuraminidase,  the other half 
was mock treated. (a) The left lanes show immunoprecipitated class I com- 
plex after mock fusion of labeled T2 cells with RMA cells, the middle 
lanes show this after fusion  with RMA cells, and in the right lanes the 
result after fusion with RMA-S cells is shown. Boxed areas indicate the 
position where  sialylated  HLA-B5 molecules  are  detected. (b) W6/32 
precipitations after fusion of labeled T2 cells with T1, T2, and mock fu- 
sion with T1 cells, respectively. The different forms of HLA-B5 are indi- 
cated on the right, and an unidentified heavy chain product, possibly a 
class I C-locus product (n). 
the quality control mechanisms that preclude ef~cient sur- 
face deposition  of class I  molecules devoid of peptide are 
different for human and mouse cells. The results from cell 
fusion experiments performed between RMA-S and T2 fur- 
ther suggests the defect to involve homologous functions if 
not the identical genes. While this manuscript was in prepa- 
ration, the transfection of RMA-S with TAP2 (HAM2 or 
mtp2) was reported (35-37). This transfection rescues, at least 
in part, surface expression of class I molecules. The inability 
to restore transport of class I molecules in the T2 cell line 
by fusion with RMA-S cytoplasts is thus most likely due to 
the fact that both cell lines share the lack of (functional) TAP-2 
protein.  In addition,  the T2 cell line has been shown to lack 
the TAP1 (PSF1) subunit  of the presumed  peptide  trans- 
porter complex (35), as well as an MHC-encoded proteasome 
subunit (23). 
HLA-A2 is remarkable in its capacity to be expressed at 
the cell surface under conditions  where other HLA class I 
alleles are retained intracellularly  (9,  10; Fig. 2). This may 
reflect the capacity of the HLA-A2 molecule to be loaded 
with peptides  of a different intracellular  source (38). 
In the course of the experiment, ~2M is lost from W6/32 
immunoprecipitates  prepared from T2 but not from T1, and 
the stability of dass I complexes formed by T2 is apparently 
decreased. The reduced stability of the class I complexes syn- 
thesized by T2 is also reflected by the behavior of the HLA- 
A2 and HLA-B5 class I complexes of T2 in cell lysates. The 
HLA-B5 complex is unstable at temperatures >25~  while 
incubation >35~  results in only a slight  decrease in the 
amount of W6/32-reactive material for HLA-A2. We favor 
the notion that empty class I molecules partially unfold, but 
do not necessarily dissociate at elevated temperatures,  as no 
increase of free heavy chains occurs where a reduction in the 
W6/32-reactive complexes is observed. Addition to the T2 
cell lysate of naturally processed peptides, isolated by TFA 
extraction from a HLA-B5-expressing cell line, prevents dis- 
appearance of the W6/32 epitope on the HLA-B5 complex 
when exposed to elevated temperatures.  We conclude that 
absence of peptide from the HLA-B5 complex in T2 con- 
tributes  to the observed thermolability. 
The use of anti-HLA heavy chain-specific antibodies with 
strong locus preference  in their reactivity in immuno-electron 
microscopy has allowed us to define for the first time the 
intraceUuIar localization of HLA class I molecules in T2 at 
the ultrastructural level. Quantitation of plasma membrane 
labeling for T1 and T2, shows that the cell surface levels of 
HLA-A2 and -B5 are determined accurately by this method. 
The intracellular localization of  both HLA-A2 and HLA-B5 
is affected in T2:  a sixfold accumulation of both alleles is 
observed in the EK of T2 relative to T1. Double labeling 
for the cis- and trans-Gol~ markers P53 and galactosyl trans- 
ferase, respectively, shows that both HLA-A2 and HLA-B5 
can still be transported into the Golgi area. In the Golgi com- 
plex, the ratio of HLA-A2 to HLA-B5 is markedly different 
from that observed at the cell surface of T2. Regulation of 
cell surface expression of empty class I molecules thus ap- 
pears to be regulated not only in the EK, but also at or be- 
yond the Golgi level. Reduction of culture temperature did 
not result in accumulation of class I material in the c/s-Golgi 
area (data not shown), as has been reported for another cell 
line (17), a finding interpreted to be due to recycling of  empty 
class I molecules between EK and the Golgi complex. The 
exact site at which class I molecules combine with peptide 
could therefore include the Golgi complex, and not just the 
EK,  as is commonly assumed. 
Our data would be compatible with a model in which the 
quality control of  class I molecules in the biosynthetic pathway 
utilizes  peptide  occupancy as  a criterion.  Dissociation  of 
chaperonin-type proteins may also serve this function. In any 
case, the disturbance of the ratio of HLA-A locus to HLA-B 
locus products is not detectable in the EK and Golgi com- 
plex of T2, while readily observed at the cell surface. We 
therefore propose that this quality control is not limited to 
the EK, but extends to the Golgi complex as well. 
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